-
Wednesday, 5 Nov, 2025Registration8:00 AM - 8:55 AMMorning Sessions
Chairperson’s Opening Remarks
Time:8:55 AM - 9:00 AMSession Type:General Session (Presentation)Unlocking Investment to Close the Women’s Health Gap
- Understand how leaders across sectors are harnessing the opportunity of addressing women’s health
- Learn where the opportunities are to reap the health and economic returns of closing the gap
- Get strategic insights on where the health of women market is heading – and how stakeholders can stay ahead
Speaker(s):Lucy Perez
Senior Partner, McKinsey & CoGlobal Leader, McKinsey Health InstituteLucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.
Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America. She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.
Lucy works extensively with number of biopharma and life science clients on broad range of topics, with recent focus on ESG/ sustainability, evidence generation, and digital/analytics programs to improve patient outcomes and support sustainable, inclusive growth.
Led efforts for a leading biopharma to define their ESG strategy, partnership strategy, and stakeholder engagement approach
Led efforts for a leading biopharma to embed health equity as a core principle in their R&D priorities and ways of working across the value chain
Led efforts to assess internal and external portfolio productivity and pricing models to optimize the R&D strategy and redesign the organization for a top pharmaceutical company
Led efforts for a leading biopharma to transform how it engages with customers through digital transformation, applying advanced analytics and embedding agile ways of working across their six largest markets that delivered $300M+ of near-term growth
Sponsor of McKinsey’s Early Stage Investor Conference, an annual event convening 200+ entrepreneurs and 1000+ investors interested in bio/med/health tech and sustainability innovation
Before joining McKinsey, Lucy was a research fellow at Memorial Sloan-Kettering Cancer Center, where she was involved in the development of novel treatments for solid tumors. She was also a Howard Hughes Medical Institute research fellow at Harvard University while completing her doctoral studies. She is co-inventor on multiple patents and has published in peer-reviewed journals.
Session Job Focus:Time:9:00 AM - 9:30 AMSession Type:General Session (Presentation)What are Payers Looking For? Priorities & Advancements in Women’s Health
- How can companies evidence value to payers in relation to existing solutions and models?
- As women’s health evolves, what areas are of greatest interest to payers?
- Exploring women’s health through a value-based care, Medicaid, government, and population health lens.
Speaker(s):Dianne Balon
SVP of GovernmentBlue Cross AlbertaKatie Ryan
Experience Strategy & Transformation LeadHumanaAlice Zheng, MD, MBA, MPH
PrincipalForeground CapitalSession Job Focus:Time:9:30 AM - 10:00 AMSession Type:General Session (Presentation)Networking Break10:00 AM - 11:00 AMMorning SessionsInvestor Reverse Pitching: What are we looking for?
Hear from investors with a range of funds, interests, and rounds available to companies active in healthcare sectors that only, differently, or disproportionately affect women. Tailor your company pitch to meet the needs of these investment experts.
Speaker(s):Anna Valcheva
Venture PartnerAlumni Ventures GroupMegan Dover
Principal and Co- FounderCross-Border Impact VenturesRachel Springate
Founding PartnerMuse CapitalAra Abrahamian
Vice President, Strategy & Corporate Development (Nutraceuticals), OtsukaManaging Director, ONCE VenturesMira Kaufman
Investment AssociateIngeborg InvestmentSession Job Focus:Time:11:00 AM - 11:50 AMSession Type:General Session (Presentation)Actionable Funding Paths & Derisking Investment
- Concrete guidance on accessing non-dilutive and dilutive funding—what’s available, what’s working, and how to get it.
- Strategies for founders and funders to navigate uncertainty and build investable, scalable ventures in women's health.
- How women, as both innovators and investors, are transforming the funding ecosystem—and how to leverage that shift now.
Speaker(s):Lisa Marceau
CEOJoyuusNaseem Sayani
Director, Innovators CircleWHAMTime:11:50 AM - 12:20 PMSession Type:General Session (Presentation)Lunch Break12:20 PM - 1:30 PMAfternoon SessionsDigital Health & Services Showcase Competition
From the latest apps, wearables, digital therapeutics and diagnostics, AI and M/L, the Startup Showcase brings you 6 investor selected seed & series A disruptors poised to transform consumer women’s health.
Join this rapid-fire pitching session to hear from our startup finalists, followed by questions from a judging panel of expert investors. Come along to see the who’s who dominating the startup landscape.
Session Job Focus:Time:1:30 PM - 2:30 PMAgenda Track No.:Track 1Session Type:TrackDemocratizing Access to Fertility Care
- Exploring how advancements in the fertility industry improving success rates translates into greater access.
- How policy and business models can provide opportunities regardless of geography, income, background, and sexuality.
Session Topics:FertilitySpeaker(s):Dr. Neel Shah
Chief Medical OfficerMaven ClinicLynn Mason
Chief Executive OfficerIVI RMA GLOBALKate Devine
Chief Research OfficerUSFertilityTime:1:30 PM - 2:00 PMAgenda Track No.:Track 2Session Type:TrackCare Models Driving Improved Outcomes in Maternal Health
- Delving into how policy and insurance coverage is shaping national maternal health standards.
- Showcasing Kaiser Permanente’s approach to value-based care models, accessibility, and population health.
- How the ‘cocoon model’ surrounds women with holistic supportive care beyond clinical monitoring during pregnancy.
Session Topics:Maternal HealthSpeaker(s):Esme Cullen
Chief Health Equity Officer, National Medicaid & State ProgramsKaiser PermanenteJocelyn Audelo
Senior Director, National Women’s & Children’s Health Clinical ProgramKaiser PermanenteSession Job Focus:Time:1:30 PM - 2:00 PMAgenda Track No.:Track 3Session Type:TrackThe Future of Fertility Technology
Session Topics:FertilitySpeaker(s):Eduardo Hariton
Managing Director, Fertility Innovation FundUS FertilityKay Waud
REI PhysicianHRC FertilityTime:2:00 PM - 2:30 PMAgenda Track No.:Track 2Session Type:TrackDoula Care, Reimbursement, and Policy to Shape Maternal Health Outcomes
Session Topics:Maternal HealthSpeaker(s):Nididiamaka Amutah-Onukagha
ProfessorTufts University School of MedicineSession Job Focus:Time:2:00 PM - 2:30 PMAgenda Track No.:Track 3Session Type:TrackTherapeutics, Med Device, Diagnostics Showcase Competition
From the latest drug developments, diagnostic devices and tools, the Startup Showcase brings you the best of the best innovators disrupting the space.
Join this rapid-fire pitching session to hear from our 6 seed / series A startup finalists developing the next generation of regulated medical products, followed by questions from a judging panel of expert investors. Come along to see the who’s who dominating the startup landscape.
Session Job Focus:Time:2:30 PM - 3:30 PMAgenda Track No.:Track 1Session Type:TrackBuilding Strategic Partnerships Across Fertility and Women’s Health Frontiers
- How fertility companies are expanding into broader women’s health areas like menopause, sexual health, and mental health and the partnership opportunities this creates for more holistic patient care.
- How addressing reproductive, mental, and metabolic health can translate to fertility success.
- Patient-centred approaches that leverage collaborations to address unmet needs across a woman's entire lifespan, including reproductive, mental, and cardiovascular health.
Session Topics:FertilityReproductive HealthSpeaker(s):Janet Choi
Chief Medical OfficerProgynyTime:2:30 PM - 3:00 PMAgenda Track No.:Track 2Session Type:TrackEmerging Technologies for Maternal Health Management
- How remote monitoring and wearables are improving maternal outcomes through data-backed decision making.
- Addressing the “fourth trimester” with digital tools and at home care.
- Investment, commercialization, and coverage strategies for maternal health technology.
Session Topics:Maternal HealthSpeaker(s):Rachel Springate
Founding PartnerMuse CapitalSession Job Focus:Time:2:30 PM - 3:00 PMAgenda Track No.:Track 3Session Type:TrackStreamlining Financial Pathways to Expand Fertility Access
- Navigating the financial pathways of fertility care, addressing complexities in coverage across the clinical journey.
- Exploring how leaders are using insurance innovation, employer benefits, fintech tools, and electronic health records to reduce friction, increase cost transparency, and help more patients access the care they need.
Session Topics:FertilitySpeaker(s):Chloe Cai
CEONew Hope Fertility CenterSheeva Talebian
Reproductive EndocrinologistCCRM New YorkSession Job Focus:Time:3:00 PM - 3:30 PMAgenda Track No.:Track 2Session Type:TrackBehavioural Health’s role in Advancing Mental Health for New Mothers
- Uncover the technologies and breakthroughs around behavioural health practices
- Prescribing behavioural health support strategies are effective for tackling mental health for new mothers.
- How to maintain good mental, physical, and emotional health across the day-to-day life.
Session Topics:Maternal HealthBrain HealthSpeaker(s):Leslie Forde
CEO & FounderMom's Hierarchy of NeedsTara Harding
OwnerSimply You ClinicTime:3:00 PM - 3:30 PMAgenda Track No.:Track 3Session Type:TrackNetworking Break3:30 PM - 4:00 PMAfternoon SessionsHow Stigma in Women’s Health Influences Consumer Market Dynamics
- Sharing consumer insights into how stigma surrounding women’s health influences purchasing and channel engagement.
- The role of branding and education in normalizing conversations and driving purchasing behavior.
- How businesses can collaborate to improve trust, and empower women to center their own health needs.
Speaker(s):Jenny Fisher
Head of Strategy & Transformation, Adult Feminine CareKimberly ClarkMira Kaufman
Investment AssociateIngeborg InvestmentSession Job Focus:Time:4:00 PM - 4:30 PMAgenda Track No.:Track 4Session Type:TrackCreating a Support System for Miscarriage
- Sharing personal stories of RPL and miscarriage, what factors play a role and the outcome this has on families.
- How employers, healthcare providers, and insurers can better support women experiencing miscarriage.
- Opportunities to tackle miscarriage through mental health resource, education, technology, and partnerships.
Session Topics:Reproductive HealthMaternal HealthSpeaker(s):Cindy Rahman
President & CEOMarch of DimesBrandi Howard
Senior VP of Clinical AffairsGenBioProTime:4:00 PM - 4:30 PMAgenda Track No.:Track 5Session Type:TrackThe Evolution and Uptake of Personalised, Woman-centred Menopause Plans
- Examining the growing uptake in menopause treatments that cater specific stages and symptoms of menopause.
- Ensuring that personalized menopause treatments are accessible to all women, including socio-economic, cultural, and healthcare system barriers.
- Analyzing trends in provider menopause education & support and payer coverage for holistic menopause care.
Session Topics:Menopause and LongevitySpeaker(s):Asima Ahmad
Chief Medical OfficerCarrot FertilityClaire Gill
CEOMenopause FoundationJannine Versi
CEOElektra HealthTime:4:00 PM - 4:30 PMAgenda Track No.:Track 6Session Type:TrackHealth Data in Women’s Hands and Clinical Practice
- How can we maximise the use of real time data driven by wearables, at-home diagnostics, and digital health platforms across the women’s health ecosystem.
- Creating business opportunities in leveraging women’s health data for product innovation, personalized care, and strategic partnerships with healthcare and retail.
Speaker(s):Dorothy Kilroy
Chief Commerical OfficerOuraFlorence Comite
CEO & FounderComite Center for LongevityRhiannon White
CEOClueSylvia Kang
CEOMiraSession Job Focus:Time:4:30 PM - 5:00 PMAgenda Track No.:Track 4Session Type:TrackHow Telehealth is Transforming Care Delivery and Access for Reproductive Health
- Sharing how the telehealth industry is evolving to cater the needs of women across states and regions in the US.
- Discussing how virtual care supports patient access in stigmatised health conditions and abortion care.
- Where and when telehealth is the optimal means of engagement in women’s health and how telehealth companies can tailor to the needs of women.
Session Topics:Reproductive HealthSpeaker(s):Jenny Sheehan
Director of Access SupportNational Abortion FoundationAngel Foster
Co-FounderThe Massachusetts Medication Abortion Access Project (The MAP)Dr. Angel M. Foster is a Professor in the Faculty of Health Sciences at the University of Ottawa and the 2024-2029 University Research Chair in Medication Abortion Studies. A 1996 Rhodes Scholar, she holds a doctorate from the University of Oxford, an MD from Harvard Medical School, and both master’s and bachelor’s degrees from Stanford University. Dr. Foster is a global abortion researcher and leads projects in 22 countries. She has authored more than 150 articles, co-edited three books, and serves as the Editor-in-Chief of Perspectives on Sexual and Reproductive Health. She received the Guttmacher Institute’s 2017 Darroch Award for Excellence in Sexual and Reproductive Health Research and was inducted into the Canadian Academy of Health Sciences in 2023.
Yenee Bekele
Clinical DirectorFeminist Center for Reproductive JusticeUshma Upadhyay
ProfessorUCSFSession Job Focus:Time:4:30 PM - 5:00 PMAgenda Track No.:Track 5Session Type:TrackLongevity Solutions to Prevent Poorer Health Outcomes Across Women’s Health Span
- Shed light on Mayo Clinics’ expansion into longevity medicine and the benefits this field has for women.
- Discussing the role of AI and pharmaco-genetics, and how this is weighed against food as medicine, mental health, and wellness plans.
- How diagnosis influences lifestyle medicine from pre-conception to menopause and across a women’s reproductive health journey.
Session Topics:FertilityMenopause and LongevitySpeaker(s):Adrijana Kekic
Associate Director, Experiential Education PharmacyMayo ClinicRashmi Kudesia
Reproductive EndocrinologistCCRM HoustonTime:4:30 PM - 5:00 PMAgenda Track No.:Track 6Session Type:TrackBuilding the Digital Infrastructure to Succeed in Women’s Digital Health
- Sharing examples of partnerships between technologies enabling scalable and sustainable femtech solutions across fertility, menopause, and maternal health.
- Learn how infrastructure & software services are bridging data, clinical care, and benefits to power integrated women's health ecosystems.
- Hear from leaders building the digital backbone that supports innovation, provider partnerships, and better patient outcomes through patient monitoring & engagement
Speaker(s):Tamara Orlova
CFOFlo HealthSession Job Focus:Time:5:00 PM - 5:30 PMAgenda Track No.:Track 4Session Type:TrackRobotics and Imaging in the Next Generation of Reproductive Health
- Integrating advanced MRI and ultrasound to enable surgical pre-staging and personalized planning.
- Expanding access to robotic-assisted excision surgery to address the shortage of trained surgeons and technologies.
- Bridging clinical innovation and business investment to scale precision care models.
Session Topics:Reproductive HealthSpeaker(s):Time:5:00 PM - 5:30 PMAgenda Track No.:Track 5Session Type:TrackGut Instinct: How Diet & Nutrition Feed Healthy Menopause Management
- How the demand for menopause-focused functional foods, probiotics, and supplements is shaping new business opportunities.
- Sharing insights into how nutrition and food as medicine links bone, heart, and brain health in menopause and the opportunity to address these health outcomes through wellness.
- Expanding access to menopause nutrition solutions through pharmacies, e-commerce, consumer wellness, and employer plans.
Session Topics:Menopause and LongevityNutrition and Food as MedicineSpeaker(s):Jacqueline Oliveira-Cella
FounderwellBe ConsultingLaura Katz
CEOHelainaMargarita Ochoa-Maya
Reproductive Endocrinologist & Senior Medical DirectorAmgenTime:5:00 PM - 5:30 PMAgenda Track No.:Track 6Session Type:TrackNetworking Drinks Reception5:30 PM -
Thursday, 6 Nov, 2025Registration8:00 AM - 8:55 AMMorning Sessions
Chairperson’s Opening Remarks
Time:8:55 AM - 9:00 AMSession Type:General Session (Presentation)Regulatory Landscape Surrounding Women’s Health Drugs & Devices
- Understanding FDA approval pathways for women's health drugs and devices.
- Addressing regulatory gaps and challenges in clinical trial design and data collection.
- Strategies for working with regulators to accelerate innovation and ensure patient safety.
Session Job Focus:Time:9:00 AM - 9:30 AMSession Type:General Session (Presentation)Generating Cardiovascular Clinical Outcomes for Women’s Number 1 Killer
- Addressing the under-representation of women in cardiovascular studies and how data-driven clinical outcomes are essential for tailored treatments.
- How new technologies, screenings, and wearables are improving early detection and prevention of heart disease in women.
- How partnerships between healthcare providers, pharmaceutical companies, device, and tech companies, can drive better cardiovascular outcomes for women.
Session Topics:Cardiovascular HealthSpeaker(s):Tracy Warren
Senior Managing Director, Go Red for Women FundAmerican Heart AssociationNisha Parikh
System Director, Women’s Heart ProgramNorthwell HealthTime:9:30 AM - 10:00 AMSession Type:General Session (Presentation)Building a Women’s Health Innovation Ecosystem
- Sharing perspectives from leaders in women's health, entrepreneurship, ecosystem building, and investment to explore the creation of thriving FemTech ecosystems.
- Delving into FemTechAZ's model, dissecting key barriers facing innovation, and outlining practical strategies for building supportive regional networks.
- Featuring insights from market validation and mission to establish Arizona as a blueprint for developing regional innovation ecosystems.
Speaker(s):Susan Sly
Founder & CEOThe Pause.aiSusan Sly is the Co-CEO and cofounder of RadiusAI (RAI), an award-winning visual intelligence company specializing in the retail and healthcare sectors. RAI is currently implementing its smart retail solution at the edge for a national retailer with 1,000 locations.
RAI has been named one of the fastest growing startups in Phoenix three years in a row and won VentureBeat’s AI Innovation at the Edge Award in 2022, beating out several highly acclaimed technology companies.
Prior to cofounding RAI, Susan led channel sales teams in three sectors generating over $2 billion in revenue. In her spare time, Susan is the host of the highly acclaimed podcast, Raw and Real Entrepreneurship, mom of five, wife, and tech investor. Susan has appeared on CNN, CNBC, Fox, ABC Family, and is a member of the prestigious Forbes Business Council.
Sidnee Peck
Co-FounderFemtechAZAzin Radsan van Alebeek
Co-Founder & General PartnerEmmeline VenturesMitzi Krockover
Co-Founder, FemtechAZManaging Director, Golden Seeds, CEO, Woman CenteredScarlett Spring
Executive DirectorPhoenix Bioscience CoreSession Job Focus:Time:9:30 AM - 10:00 AMSession Type:General Session (Presentation)Networking Break10:00 AM - 11:00 AMMorning SessionsThe Cost of Accessible Contraception
- Discussing the financial burden associated with contraception, gaps in coverage, and how this influences retail access.
- Sharing commercial opportunities by making low-cost contraception more available through ecosystem partnerships.
- How can the industry operationalize OTC coverage and distribution of contraception and other women’s health medications.
Speaker(s):Victoria Nichols
Senior Project Director, Free the PillIbis Reproductive HealthFlavia Mason
Global Vice President, Women's HealthPerrigoSession Job Focus:Time:11:00 AM - 11:30 AMAgenda Track No.:Track 4Session Type:TrackHolistic Approaches to Tackling Social Determinants of Maternal Health
- Exploring how housing, nutrition, identity, and income shape maternal outcomes.
- Highlighting programs and solutions that integrate social support with clinical care.
- Discussing actionable strategies in the clinical setting that embed accessibility and education into maternal health systems.
Session Topics:Nutrition and Food as MedicineMaternal HealthSpeaker(s):Nawal Nour
Chair & Director of Obstetrics & GynecologyBrigham and Women’s HospitalTime:11:00 AM - 11:30 AMAgenda Track No.:Track 5Session Type:TrackFrom Pre-Launch to Payer Buy-In: Educating the Commercial Healthcare Ecosystem
- How to mitigate inappropriate drug use and dosing risk, leveraging mechanisms like Pre-Approval Information Exchange (PIE) and PDUFA timelines to shape understanding of indication, value, and safety.
- How to engage payers as early as phase 2 to build trust and tailor future value-based contracts, launching with outcomes-driven frameworks to support access and reimbursement.
Speaker(s):Jim Kenney
Founder – JTKENNEYFormer Manager, Specialty and Pharmacy Contracts - Harvard Pilgrim Health CareSession Job Focus:Time:11:00 AM - 11:30 AMAgenda Track No.:Track 8Session Type:TrackBeyond Contraception – How Consumer-wellness Solutions are Addressing Menstrual Health & Cycle Symptoms
- Holistic approaches to addressing the full spectrum of menstrual and hormonal symptoms, including pain, mood changes, sleep, and fatigue.
- Sharing consumer insights and opportunities to implement alternative solutions for menstrual health, sharing learnings from successful engagement strategies.
- Learn how the consumer health industry is conducting new research to drive access, education, and science-backed tools forward.
Speaker(s):Sasha Kalcheff-Korn
Executive DirectorRealm of CaringSession Job Focus:Time:11:30 AM - 12:00 PMAgenda Track No.:Track 4Session Type:TrackStreamlining Diagnosis in Reproductive Health Through Technology & Epidemiology
- Leveraging tech and epidemiological data to reduce diagnostic delays in reproductive health.
- Exploring AI, biomarkers, digital therapeutics, and digital platforms that enable earlier and more accurate diagnoses.
- Advice to start-ups and sharing the market opportunity for clinical integration in preventative & diagnostic women’s health.
Session Topics:Reproductive HealthSpeaker(s):Miller Morris
CEOCommaSession Job Focus:Time:11:30 AM - 12:00 PMAgenda Track No.:Track 5Session Type:TrackFrom Complexity to Clarity: Harnessing Data and AI to Transform Cost Models in Women’s Healthcare
- How payers can apply AI and predictive analytics to optimize cost structures in women’s healthcare.
- The role of structured and unstructured data in improving patient outcomes and reducing financial barriers.
- Actionable insights for startups: what data to prioritize and how to maximize its value when working with payers and providers.
Speaker(s):Angela Rastegar
CEOSunfishSession Job Focus:Time:11:30 AM - 12:00 PMAgenda Track No.:Track 8Session Type:TrackLikes, Trust, and Baby Dust: Social Media Strategies for Fertility & Reproductive Health Practices
- Discussing the emerging trends of women’s health education & awareness on social media.
- How companies can best utilize social media for marketing & business opportunity.
- Addressing misinformation, trust and health literacy impacting health & wellness decision-making.
Session Topics:Reproductive HealthFertilitySpeaker(s):Roohi Jeelani
Chief Growth OfficerKindbodySession Job Focus:Time:12:00 PM - 12:30 PMAgenda Track No.:Track 4Session Type:TrackGenomic & Data Driven Approaches to Optimize Clinical Outcomes
- Elucidating how researchers are using menstrual effluent to track fertility, inflammation, and disease.
- Consumer Adoption & Clinical Validation – The path to making menstrual-based diagnostics a mainstream health tool.
- Investment & Industry Growth – The market potential of menstrual-based biomarkers in diagnostics and therapeutics.
Session Topics:Reproductive HealthSpeaker(s):Lara Zibners
Co-FounderCalla Lily Clinical CareTime:12:00 PM - 12:30 PMAgenda Track No.:Track 5Session Type:TrackFireside Chat: Priorities for Supporting Women in the Workforce
- How employers are integrating fertility, menopause, and maternal health into employee health plans.
- Addressing workplace challenges like menstrual health, caregiving, and chronic conditions.
- The ROI of Women's Health Investment – How employer-driven health initiatives improve retention.
Session Topics:Brain HealthNutrition and Food as MedicineSpeaker(s):Maxine Carrington
Chief People OfficerNorthwell HealthSession Job Focus:Time:12:00 PM - 12:30 PMAgenda Track No.:Track 8Session Type:TrackLunch Break12:30 PM - 1:30 PMAfternoon SessionsDefining Product-Market Fit in Digital Health to Enable Scalability
- Demystifying product-market fit in the context of digital health, where clinical need, usability, and reimbursement must align.
- Identifying key indicators—user adoption, engagement, and outcomes—that show readiness to scale.
- Strategies for translating validated need into scalable, sustainable digital health solutions.
Speaker(s):Session Job Focus:Time:1:30 PM - 2:00 PMAgenda Track No.:Track 4Session Type:TrackSafety Profiles & Women’s Reproductive Drug Development
- How can pre-trial screening effectively predict side effects and symptoms associated with reproductive therapeutics.
- What are the appropriate safety profiles to apply for endometriosis, PCOS, and fibroids.
Session Topics:Reproductive HealthSpeaker(s):Johan van Hylckama
CSOFreya BiosciencesSession Job Focus:Time:1:30 PM - 2:00 PMAgenda Track No.:Track 7Session Type:TrackUnderstanding the Development of Alzheimer’s in Women
- Sharing new clinical outcomes and how clinical trials are evolving.
- Exploring the link between menopause, estrogen, and cognitive decline.
- How biomarkers, digital tools, and lifestyle interventions can improve outcomes.
Session Topics:Brain HealthTime:1:30 PM - 2:00 PMAgenda Track No.:Track 8Session Type:TrackHybrid vs Complete Telehealth Integration Across Markets: what’s not working & what’s the opportunity?
- What are the outcomes that payers are seeing from telehealth deployment in terms of access, costs, and efficiency?
- What is the impact of digital health on hybrid models such as pregnancy vs wider health conditions?
- How can we maximize the deployment of telehealth in women’s health?
Time:2:00 PM - 2:30 PMAgenda Track No.:Track 4Session Type:TrackAccelerating Clinical Validation of Therapeutics through Biomarker Discovery
- Explore how biomarker-driven approaches are streamlining trial design, improving patient stratification, and accelerating time-to-approval for women’s health therapeutics.
- Learn how collaborations between industry, academia, biotech, and pharma are turning early-stage biomarker insights into clinically actionable endpoints.
- How to maximise the use of biobanks in biomarker discovery.
Speaker(s):Sanj Singh
CEOTemple TherapeuticsTime:2:00 PM - 2:30 PMAgenda Track No.:Track 7Session Type:TrackEnabling Breast & Cervical Cancer Screening Accessibility
Exploring the current landscape of screening services in women’s cancers and market opportunities to address unmet need.
Sharing how AI, technology, and genetic testing can address gaps in access.
How providers and patients can be equipped with tools for early detection and cancer prevention.
Session Topics:OncologySpeaker(s):Andrea Olariu
CEOMedicines360Session Job Focus:Time:2:00 PM - 2:30 PMAgenda Track No.:Track 8Session Type:TrackNetworking Break2:30 PM - 3:00 PMAfternoon SessionsHow Agentic AI is set to Transform the Landscape of Healthcare
- Sharing where and when Agentic AI is going to be implemented, from clinical trials to provider assistance.
- What Agentic AI means for the women’s health industry, opportunities and challenges to implement across workflows.
- The impact of Agentic AI on health systems and digital platforms to support scalability and efficiency.
Time:3:00 PM - 3:30 PMAgenda Track No.:Track 4Session Type:TrackBridging Clinical Development & Licensing in Women’s Health
- Learn how to align clinical development strategies with licensing milestones to accelerate commercialization in women’s health.
- Explore what pharma and late stage investors look for in licensing-ready assets, from early efficacy signals to regulatory preparedness.
- Understand how to navigate clinical, legal, and market access challenges unique to women’s health to build a compelling licensing case.
Speaker(s):Oliver Bates
Chief Executive OfficerViramalSession Job Focus:Time:3:00 PM - 3:30 PMAgenda Track No.:Track 7Session Type:TrackMenopause Data Advancements in Clinical Practice & Research
- Discuss strategies for trial design that account for hormonal fluctuations, comorbidities, and age-related variables unique to the menopausal transition.
- Highlight regulatory, industry, and advocacy efforts that are pushing for menopause-specific representation in therapeutic areas beyond just women’s health.
- Sharing advancements to educate clinical trial patients about menopause.
Session Topics:Menopause and LongevitySession Job Focus:Time:3:00 PM - 3:30 PMAgenda Track No.:Track 8Session Type:TrackA Novel Oncolytic Peptide for Triple Negative Breast Cancer Therapy
- Explore the mechanism of action and preclinical efficacy of a first-in-class oncolytic peptide targeting triple negative breast cancer (TNBC).
- Understand how peptide-based approaches offer new hope for aggressive and treatment-refractory subtypes of breast cancer.
- Learn about the breast cancer therapeutic roadmap and landscape.
Session Topics:OncologySpeaker(s):Mark Eccleston
Chief Executive OfficerValiRxSession Job Focus:Time:3:30 PM - 4:00 PMAgenda Track No.:Track 7Session Type:TrackData-driven Drug Discovery in Women’s Health & Reproductive Medicine
- Discover how real-world data, genomics, and AI are revealing new targets and mechanisms in female-specific and reproductive conditions.
- Learn how data integration is shortening timelines from target identification to preclinical validation.
- Sharing insights into novel drug discovery approaches, the use of AI, multi-omics data, and 3D models.
Session Topics:Reproductive HealthSpeaker(s):Stasa Stankovic
Chief Executive OfficerOvartixSession Job Focus:Time:4:00 PM - 4:30 PMAgenda Track No.:Track 7Session Type:TrackAdvancing Clinical Trial Design for Women’s Drugs & Devices
- Sharing the role of technology and partnerships in the design & recruitment of studies.
- Highlighting adaptive trial designs, decentralized models, and inclusive recruitment strategies.
- Exploring how smarter trial design accelerates approval, reduces risk, and improves real-world outcomes.
Time:4:30 PM - 5:00 PMAgenda Track No.:Track 7Session Type:General Session (Presentation)End of WHIS 2025
Jump to: Wednesday, 5 Nov | Thursday, 6 Nov